Introduction:

In a landmark ruling, the Supreme Court of India has held that stem cell banking services—including enrolment, collection, processing, and storage of umbilical cord blood stem cells—constitute “Healthcare Services” under the Finance Act, 1994 and are thus exempted from service tax as per Notifications No. 25/2012-ST (dated 20.06.2012) and No. 4/2014-ST (dated 17.02.2014). The judgment was delivered by a bench comprising Justice J.B. Pardiwala and Justice R. Mahadevan in the case M/s Stemcyte India Therapeutics Pvt. Ltd. v. Commissioner of Central Excise and Service Tax, Ahmedabad-III, which arose from a challenge to assessment orders imposing service tax liability of over ₹2 crores on the appellant for the period between 01.07.2012 and 16.02.2014. The Court’s decision provides significant clarity on the classification of emerging medical services within the tax framework and reinforces the broad scope of healthcare services under Indian law.

Arguments by the Appellant:

The appellant, M/s Stemcyte India Therapeutics Pvt. Ltd., argued that their core services—collection, testing, processing, cryopreservation, and release of umbilical cord blood (UCB) stem cells for potential therapeutic use—are inherently linked to healthcare. Counsel emphasized that these services are preventive in nature and aimed at safeguarding health against future medical conditions. They cited Entry 2 of Notification No. 25/2012-ST, which exempts services provided by clinical establishments by way of “healthcare services,” including diagnosis, treatment, and care for illness, injury, deformity, abnormality, or pregnancy.

The appellant stressed that stem cell banking is a globally recognized medical procedure that facilitates treatment of life-threatening conditions such as blood disorders, certain cancers, and immunodeficiency diseases. They further argued that their activities involve medical expertise, compliance with regulatory standards under the Drugs and Cosmetics Act, and collaborations with international medical institutions for research and clinical trials. Therefore, these services cannot be classified as commercial activities unrelated to health but must fall within the definition of healthcare services.

The appellant also relied on the Ministry of Health and Family Welfare’s Office Memorandum dated 22.05.2013, which clarified that stem cell banking forms an integral part of healthcare services. They further cited the Andhra Pradesh High Court decision in M. Satyanarayana Raju Charitable Trust v. Union of India, which interpreted healthcare to include preventive and curative measures.

Additionally, the appellant contended that the insertion of Entry 2A by Notification No. 4/2014-ST (which explicitly exempted cord blood banking services from service tax from 17.02.2014) was merely clarificatory and not restrictive. Therefore, the exemption applied even before this date under the broad definition of healthcare services in Notification No. 25/2012-ST.

Arguments by the Department:

The Department opposed the appellant’s claims, asserting that the exemption for stem cell banking services was expressly introduced only on 17.02.2014 via Notification No. 4/2014-ST through Entry 2A. Before this date, according to the Department, such services were not covered under the ambit of healthcare services. They argued that the appellant’s services did not directly constitute diagnosis, treatment, or care for any illness or abnormality but were commercial in nature, involving storage for a fee for possible future use.

The Department further maintained that exemption notifications should be interpreted strictly, and in the absence of explicit coverage of cord blood banking in Notification No. 25/2012-ST, the appellant could not claim the benefit of exemption retrospectively. According to the Department, the legislature’s decision to specifically add Entry 2A in 2014 indicated that prior to its inclusion, stem cell banking services were not intended to be exempt.

Court’s Analysis and Judgment:

The Supreme Court examined the scope and intent of Notifications No. 25/2012-ST and 4/2014-ST in detail. The Court began by interpreting Clause 2(t) of Notification No. 25/2012-ST, which defines “healthcare services” as:

 “Any service by way of diagnosis or treatment or care for illness, injury, deformity, abnormality, or pregnancy in any recognized system of medicines in India and includes services by way of transportation of the patient to and from a clinical establishment.”

The bench noted that the definition of healthcare is broad and not confined to immediate or curative treatment but includes preventive and future-oriented services. Stem cell banking, the Court observed, falls squarely within this ambit because it is a preventive measure that ensures availability of stem cells for treating serious ailments that may arise later in life. The Court drew parallels between vaccination, which is preventive, and stem cell storage, which serves a similar purpose of future readiness against medical risks.

Rejecting the Department’s contention, the Court held that the insertion of Entry 2A in 2014 did not create a new exemption but clarified an already existing position under Entry 2 of the 2012 Notification. The absence of explicit mention of cord blood banking in the earlier notification did not mean its exclusion, as the core character of the service was healthcare.

The Court further placed reliance on the Ministry of Health and Family Welfare’s Office Memorandum dated 22.05.2013, which categorized stem cell banking as part of healthcare services, and on judicial precedents recognizing preventive services within the scope of healthcare. It underscored that the appellant’s involvement in post-transplant monitoring, research, and clinical trials reinforced the healthcare nature of their services.

Consequently, the Court concluded that the assessment orders demanding service tax for the period between 01.07.2012 and 16.02.2014 were unsustainable in law. The bench set aside the impugned orders, allowing the appeal and granting full relief to the appellant. The judgment, authored by Justice R. Mahadevan, affirmed the principle that exemptions for healthcare services must be interpreted liberally to advance public health objectives rather than being curtailed through narrow interpretations.